Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3626820 | 0.86 | TRPA1 (0.33) | TRPA1TRPV1 | |
| Hydrochloric Acid SCHEMBL7420163 | 0.85 | TRPA1 (0.32) | TRPA1TRPV1 | |
| SCHEMBL1883811 | 0.79 | TRPA1 (0.60) | TRPA1TRPV1 | |
| SCHEMBL6294131 | 0.78 | — | — | |
| SCHEMBL23598722 | 0.72 | TRPA1 (0.52) | TRPA1TRPV1 | |
| SCHEMBL9542006 | 0.72 | — | — | |
| SCHEMBL20203690 | 0.72 | TRPA1 (0.52) | TRPA1TRPV1 | |
| SCHEMBL287060 | 0.70 | — | — | |
| SCHEMBL9914203 | 0.69 | — | — | |
| SCHEMBL220893 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2298736-B1 | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents | SOLULINK INC (US) | 2015-07-15 | — | — | EP | disclosed |
| EP-2295407-B1 | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents | SOLULINK INC (US) | 2014-11-05 | — | — | EP | disclosed |
| US-7462689-B2 | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents | SOLULINK BIOSCIENCES, INC. (US) | 2008-12-09 | — | — | US | disclosed |
| US-6800728-B2 | CROSSLINKING AND IMMOBILIZING BIOMOLECULES, DRUGS AND SYNTHETIC POLYMERS WITH A THIOL OR AMINO REACTIVE GROUP AND HYDRAZINO OR OXYAMINO MOIETIES | SOLULINK BIOSCIENCES, INC. | 2004-10-05 | — | — | US | disclosed |
| EP-1315699-A2 | HYDRAZINE-BASED AND CARBONYL-BASED BIFUNCTIONAL CROSSLINKING REAGENTS | Solulink, Incorporated (US) | 2003-06-04 | — | — | EP | disclosed |
| US-20030013857-A1 | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents | SOLULINK INCORPORATED | 2003-01-16 | — | — | US | disclosed |
| WO-2001070685-A2 | HYDRAZINE-BASED AND CARBONYL-BASED BIFUNCTIONAL CROSSLINKING REAGENTS | SOLULINK, INCORPORATED (US) | 2001-09-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030013857-A1 | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents | HLCS, DUOX1, HAO2 | TRPA1 4439/4885TRPV1 4540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.